What is the projected market valuation of the Cancer Photodynamic Therapy Market by 2035?

The projected market valuation for the Cancer Photodynamic Therapy Market is 4.219 USD Billion by 2035. Read More

What was the market valuation of the Cancer Photodynamic Therapy Market in 2024?

The overall market valuation was 1.97 USD Billion in 2024. Read More

What is the expected CAGR for the Cancer Photodynamic Therapy Market during the forecast period 2025 - 2035?

The expected CAGR for the Cancer Photodynamic Therapy Market during the forecast period 2025 - 2035 is 7.17%. Read More

Which cancer types are expected to drive the market growth in the Cancer Photodynamic Therapy sector?

Head and neck cancer and skin cancer are expected to drive market growth, with valuations projected at 1.1 USD Billion and 0.9 USD Billion respectively by 2035. Read More

What are the leading companies in the Cancer Photodynamic Therapy Market?

Key players in the market include Photocure ASA, DUSA Pharmaceuticals Inc, and Merck & Co Inc. Read More

What delivery methods are utilized in Cancer Photodynamic Therapy, and what are their projected valuations?

Intravenous injection and topical application are key delivery methods, with projected valuations of 1.67 USD Billion and 1.25 USD Billion by 2035. Read More

How do light sources contribute to the Cancer Photodynamic Therapy Market?

Lasers and light-emitting diodes (LEDs) are significant light sources, with projected market valuations of 1.68 USD Billion and 1.25 USD Billion respectively by 2035. Read More

What role do photosensitizers play in the Cancer Photodynamic Therapy Market?

Photosensitizers such as porphyrins and chlorins are crucial, with projected valuations of 1.68 USD Billion and 1.06 USD Billion by 2035. Read More

What applications are anticipated to expand within the Cancer Photodynamic Therapy Market?

Curative therapy and early detection are anticipated to expand, with projected valuations of 2.0 USD Billion and 1.0 USD Billion by 2035. Read More

How does the Cancer Photodynamic Therapy Market compare across different cancer types?

The market shows varied potential across cancer types, with head and neck cancer leading at 1.1 USD Billion and urological cancer at 0.5 USD Billion by 2035. Read More

Cancer Photodynamic Therapy Market

Cancer Photodynamic Therapy Market Research Report: Size, Share, Trend Analysis By Cancer Type (Head and Neck Cancer, Skin Cancer, Lung Cancer, Gastrointestinal Cancer, Urological Cancer, Gynecological Cancer), By Light Source (Lasers, Light-Emitting Diodes (LEDs), Arc Lamps), By Photosensitizer (Porphyrins, Chlorins, Phthalocyanines, Hypericin, Indocyanine Green), By Delivery Method (Intravenous Injection, Topical Application, Intra-Arterial Infusion, Photodynamic Fiberoptic System), By Applications (Early Detection, Curative Therapy, Palliative Care, Immunotherapy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.17%

2024 Market Size

$ 1.97 Billion

2035 Market Size

$ 4.22 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/28056-HCR | Pages: 128 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Cancer Type (USD Billion)
  1. 4.1.1 Head and Neck Cancer
  2. 4.1.2 Skin Cancer
  3. 4.1.3 Lung Cancer
  4. 4.1.4 Gastrointestinal Cancer
  5. 4.1.5 Urological Cancer
  6. 4.1.6 Gynecological Cancer
2. 4.2 Healthcare, BY Light Source (USD Billion)
  1. 4.2.1 Lasers
  2. 4.2.2 Light-emitting diodes (LEDs)
  3. 4.2.3 Arc Lamps
3. 4.3 Healthcare, BY Photosensitizer (USD Billion)
  1. 4.3.1 Porphyrins
  2. 4.3.2 Chlorins
  3. 4.3.3 Phthalocyanines
  4. 4.3.4 Hypericin
  5. 4.3.5 Indocyanine Green
4. 4.4 Healthcare, BY Delivery Method (USD Billion)
  1. 4.4.1 Intravenous Injection
  2. 4.4.2 Topical Application
  3. 4.4.3 Intra-Arterial Infusion
  4. 4.4.4 Photodynamic Fiberoptic System
5. 4.5 Healthcare, BY Application (USD Billion)
  1. 4.5.1 Early Detection
  2. 4.5.2 Curative Therapy
  3. 4.5.3 Palliative Care
  4. 4.5.4 Immunotherapy
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Photocure ASA (NO)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 DUSA Pharmaceuticals Inc (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Merck & Co Inc (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Galderma S.A. (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sensus Healthcare Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Aduro Biotech Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 OncoSec Medical Incorporated (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Targovax ASA (NO)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY CANCER TYPE
4. 6.4 US MARKET ANALYSIS BY LIGHT SOURCE
5. 6.5 US MARKET ANALYSIS BY PHOTOSENSITIZER
6. 6.6 US MARKET ANALYSIS BY DELIVERY METHOD
7. 6.7 US MARKET ANALYSIS BY APPLICATION
8. 6.8 CANADA MARKET ANALYSIS BY CANCER TYPE
9. 6.9 CANADA MARKET ANALYSIS BY LIGHT SOURCE
10. 6.10 CANADA MARKET ANALYSIS BY PHOTOSENSITIZER
11. 6.11 CANADA MARKET ANALYSIS BY DELIVERY METHOD
12. 6.12 CANADA MARKET ANALYSIS BY APPLICATION
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY CANCER TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY LIGHT SOURCE
16. 6.16 GERMANY MARKET ANALYSIS BY PHOTOSENSITIZER
17. 6.17 GERMANY MARKET ANALYSIS BY DELIVERY METHOD
18. 6.18 GERMANY MARKET ANALYSIS BY APPLICATION
19. 6.19 UK MARKET ANALYSIS BY CANCER TYPE
20. 6.20 UK MARKET ANALYSIS BY LIGHT SOURCE
21. 6.21 UK MARKET ANALYSIS BY PHOTOSENSITIZER
22. 6.22 UK MARKET ANALYSIS BY DELIVERY METHOD
23. 6.23 UK MARKET ANALYSIS BY APPLICATION
24. 6.24 FRANCE MARKET ANALYSIS BY CANCER TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY LIGHT SOURCE
26. 6.26 FRANCE MARKET ANALYSIS BY PHOTOSENSITIZER
27. 6.27 FRANCE MARKET ANALYSIS BY DELIVERY METHOD
28. 6.28 FRANCE MARKET ANALYSIS BY APPLICATION
29. 6.29 RUSSIA MARKET ANALYSIS BY CANCER TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY LIGHT SOURCE
31. 6.31 RUSSIA MARKET ANALYSIS BY PHOTOSENSITIZER
32. 6.32 RUSSIA MARKET ANALYSIS BY DELIVERY METHOD
33. 6.33 RUSSIA MARKET ANALYSIS BY APPLICATION
34. 6.34 ITALY MARKET ANALYSIS BY CANCER TYPE
35. 6.35 ITALY MARKET ANALYSIS BY LIGHT SOURCE
36. 6.36 ITALY MARKET ANALYSIS BY PHOTOSENSITIZER
37. 6.37 ITALY MARKET ANALYSIS BY DELIVERY METHOD
38. 6.38 ITALY MARKET ANALYSIS BY APPLICATION
39. 6.39 SPAIN MARKET ANALYSIS BY CANCER TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY LIGHT SOURCE
41. 6.41 SPAIN MARKET ANALYSIS BY PHOTOSENSITIZER
42. 6.42 SPAIN MARKET ANALYSIS BY DELIVERY METHOD
43. 6.43 SPAIN MARKET ANALYSIS BY APPLICATION
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY CANCER TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY LIGHT SOURCE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY PHOTOSENSITIZER
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY DELIVERY METHOD
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY CANCER TYPE
51. 6.51 CHINA MARKET ANALYSIS BY LIGHT SOURCE
52. 6.52 CHINA MARKET ANALYSIS BY PHOTOSENSITIZER
53. 6.53 CHINA MARKET ANALYSIS BY DELIVERY METHOD
54. 6.54 CHINA MARKET ANALYSIS BY APPLICATION
55. 6.55 INDIA MARKET ANALYSIS BY CANCER TYPE
56. 6.56 INDIA MARKET ANALYSIS BY LIGHT SOURCE
57. 6.57 INDIA MARKET ANALYSIS BY PHOTOSENSITIZER
58. 6.58 INDIA MARKET ANALYSIS BY DELIVERY METHOD
59. 6.59 INDIA MARKET ANALYSIS BY APPLICATION
60. 6.60 JAPAN MARKET ANALYSIS BY CANCER TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY LIGHT SOURCE
62. 6.62 JAPAN MARKET ANALYSIS BY PHOTOSENSITIZER
63. 6.63 JAPAN MARKET ANALYSIS BY DELIVERY METHOD
64. 6.64 JAPAN MARKET ANALYSIS BY APPLICATION
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY CANCER TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY LIGHT SOURCE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY PHOTOSENSITIZER
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY DELIVERY METHOD
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
70. 6.70 MALAYSIA MARKET ANALYSIS BY CANCER TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY LIGHT SOURCE
72. 6.72 MALAYSIA MARKET ANALYSIS BY PHOTOSENSITIZER
73. 6.73 MALAYSIA MARKET ANALYSIS BY DELIVERY METHOD
74. 6.74 MALAYSIA MARKET ANALYSIS BY APPLICATION
75. 6.75 THAILAND MARKET ANALYSIS BY CANCER TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY LIGHT SOURCE
77. 6.77 THAILAND MARKET ANALYSIS BY PHOTOSENSITIZER
78. 6.78 THAILAND MARKET ANALYSIS BY DELIVERY METHOD
79. 6.79 THAILAND MARKET ANALYSIS BY APPLICATION
80. 6.80 INDONESIA MARKET ANALYSIS BY CANCER TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY LIGHT SOURCE
82. 6.82 INDONESIA MARKET ANALYSIS BY PHOTOSENSITIZER
83. 6.83 INDONESIA MARKET ANALYSIS BY DELIVERY METHOD
84. 6.84 INDONESIA MARKET ANALYSIS BY APPLICATION
85. 6.85 REST OF APAC MARKET ANALYSIS BY CANCER TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY LIGHT SOURCE
87. 6.87 REST OF APAC MARKET ANALYSIS BY PHOTOSENSITIZER
88. 6.88 REST OF APAC MARKET ANALYSIS BY DELIVERY METHOD
89. 6.89 REST OF APAC MARKET ANALYSIS BY APPLICATION
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY CANCER TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY LIGHT SOURCE
93. 6.93 BRAZIL MARKET ANALYSIS BY PHOTOSENSITIZER
94. 6.94 BRAZIL MARKET ANALYSIS BY DELIVERY METHOD
95. 6.95 BRAZIL MARKET ANALYSIS BY APPLICATION
96. 6.96 MEXICO MARKET ANALYSIS BY CANCER TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY LIGHT SOURCE
98. 6.98 MEXICO MARKET ANALYSIS BY PHOTOSENSITIZER
99. 6.99 MEXICO MARKET ANALYSIS BY DELIVERY METHOD
100. 6.100 MEXICO MARKET ANALYSIS BY APPLICATION
101. 6.101 ARGENTINA MARKET ANALYSIS BY CANCER TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY LIGHT SOURCE
103. 6.103 ARGENTINA MARKET ANALYSIS BY PHOTOSENSITIZER
104. 6.104 ARGENTINA MARKET ANALYSIS BY DELIVERY METHOD
105. 6.105 ARGENTINA MARKET ANALYSIS BY APPLICATION
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY CANCER TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY LIGHT SOURCE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PHOTOSENSITIZER
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY DELIVERY METHOD
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY CANCER TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY LIGHT SOURCE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY PHOTOSENSITIZER
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY DELIVERY METHOD
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY CANCER TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY LIGHT SOURCE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY PHOTOSENSITIZER
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY DELIVERY METHOD
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
122. 6.122 REST OF MEA MARKET ANALYSIS BY CANCER TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY LIGHT SOURCE
124. 6.124 REST OF MEA MARKET ANALYSIS BY PHOTOSENSITIZER
125. 6.125 REST OF MEA MARKET ANALYSIS BY DELIVERY METHOD
126. 6.126 REST OF MEA MARKET ANALYSIS BY APPLICATION
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY CANCER TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY CANCER TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY LIGHT SOURCE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY LIGHT SOURCE, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY PHOTOSENSITIZER, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY PHOTOSENSITIZER, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY DELIVERY METHOD, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY DELIVERY METHOD, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.2.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.2.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.2.5 BY APPLICATION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.3.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.3.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.3.5 BY APPLICATION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.4.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.4.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.4.5 BY APPLICATION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.5.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.5.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.5.5 BY APPLICATION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.6.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.6.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.6.5 BY APPLICATION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.7.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.7.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.7.5 BY APPLICATION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.8.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.8.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.8.5 BY APPLICATION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.9.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.9.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.9.5 BY APPLICATION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.10.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.10.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.10.5 BY APPLICATION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.11.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.11.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.11.5 BY APPLICATION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.12.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.12.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.12.5 BY APPLICATION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.13.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.13.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.13.5 BY APPLICATION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.14.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.14.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.14.5 BY APPLICATION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.15.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.15.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.15.5 BY APPLICATION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.16.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.16.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.16.5 BY APPLICATION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.17.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.17.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.17.5 BY APPLICATION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.18.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.18.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.18.5 BY APPLICATION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.19.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.19.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.19.5 BY APPLICATION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.20.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.20.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.20.5 BY APPLICATION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.21.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.21.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.21.5 BY APPLICATION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.22.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.22.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.22.5 BY APPLICATION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.23.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.23.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.23.5 BY APPLICATION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.24.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.24.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.24.5 BY APPLICATION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.25.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.25.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.25.5 BY APPLICATION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.26.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.26.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.26.5 BY APPLICATION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.27.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.27.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.27.5 BY APPLICATION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.28.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.28.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.28.5 BY APPLICATION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.29.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.29.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.29.5 BY APPLICATION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY CANCER TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY LIGHT SOURCE, 2025-2035 (USD Billion)
  3. 7.30.3 BY PHOTOSENSITIZER, 2025-2035 (USD Billion)
  4. 7.30.4 BY DELIVERY METHOD, 2025-2035 (USD Billion)
  5. 7.30.5 BY APPLICATION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Cancer Photodynamic Therapy Market Segmentation

Cancer Photodynamic Therapy Market By Cancer Type (USD Billion, 2025-2035)

Head and Neck Cancer
Skin Cancer
Lung Cancer
Gastrointestinal Cancer
Urological Cancer
Gynecological Cancer

Cancer Photodynamic Therapy Market By Light Source (USD Billion, 2025-2035)

Lasers
Light-emitting diodes (LEDs)
Arc Lamps

Cancer Photodynamic Therapy Market By Photosensitizer (USD Billion, 2025-2035)

Porphyrins
Chlorins
Phthalocyanines
Hypericin
Indocyanine Green

Cancer Photodynamic Therapy Market By Delivery Method (USD Billion, 2025-2035)

Intravenous Injection
Topical Application
Intra-Arterial Infusion
Photodynamic Fiberoptic System

Cancer Photodynamic Therapy Market By Application (USD Billion, 2025-2035)

Early Detection
Curative Therapy
Palliative Care
Immunotherapy

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”